Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| SYRS | SYROS PHARMACEUTICALS INC | United States | $135.71M | 26,453,891 | 46.94% | 53.06% | Net Buying | Net Selling |
| LRMR | LARIMAR THERAPEUTICS INC | United States | $495.41M | 63,800,017 | 42.05% | 57.95% | Net Buying | Net Buying |
| MNOV | MEDICINOVA INC | United States | $64.25M | 49,046,246 | 9.85% | 89.10% | ||
| SLNO | SOLENO THERAPEUTICS INC | United States | $1.46B | 32,460,579 | 20.77% | 79.23% | Net Buying | Net Selling |
| ERAS | ERASCA INC | United States | $324.20M | 151,494,161 | 44.64% | 55.36% | Net Buying | |
| VRNA | VERONA PHARMA PLC | United Kingdom | $1.27B | 646,524,958 | 10.44% | 55.89% | Net Selling | Net Selling |
| QNCX | QUINCE THERAPEUTICS INC | United States | $42.57M | 43,215,233 | 15.43% | 84.57% | Net Buying | |
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | China | $87.61M | 55,102,954 | 12.92% | 0.00% | ||
| VOR | VOR BIOPHARMA INC | United States | $122.70M | 68,168,771 | 87.43% | 10.18% | Net Selling | Net Selling |
| ABOS | ACUMEN PHARMACEUTICALS INC | United States | $209.68M | 60,079,778 | 63.98% | 16.58% | Net Buying | |
| THRD | THIRD HARMONIC BIO INC | United States | $476.36M | 40,714,399 | 73.29% | 26.71% | Net Buying | Net Buying |
| BCRX | BIOCRYST PHARMACEUTICALS INC | United States | $917.37M | 206,149,929 | 83.05% | 16.95% | Net Selling | Net Selling |
| MACK | MERRIMACK PHARMACEUTICALS INC | United States | $217.74M | 14,516,170 | 23.49% | 76.51% | Net Buying | |
| TNGX | TANGO THERAPEUTICS INC | United States | $812.13M | 106,718,315 | 59.42% | 40.58% | Net Buying | Net Selling |
| RGNX | REGENXBIO INC | United States | $747.72M | 44,427,555 | 76.15% | 23.85% | Net Selling | Net Buying |
| ONVO | ORGANOVO HOLDINGS INC | United States | $10.34M | 10,040,074 | 4.53% | 95.47% | Net Selling | |
| NTRB | NUTRIBAND INC | United States | $38.28M | 10,969,870 | 1.78% | 51.68% | ||
| MTNB | MATINAS BIOPHARMA HOLDINGS INC | United States | $38.06M | 217,482,830 | 11.76% | 13.73% | ||
| CTMX | CYTOMX THERAPEUTICS INC | United States | $300.01M | 67,721,658 | 48.20% | 30.89% | Net Buying | Net Buying |
| AFMD | AFFIMED NV | Germany | $82.53M | 15,227,463 | 100.00% | 0.00% | ||
| APLS | APELLIS PHARMACEUTICALS INC | United States | $5.72B | 120,581,749 | 74.88% | 25.12% | Net Buying | Net Selling |
| GNLX | GENELUX CORP | United States | $102.89M | 26,865,473 | 21.54% | 5.21% | Net Selling | Net Selling |
| RCUS | ARCUS BIOSCIENCES INC | United States | $1.43B | 90,864,829 | 48.32% | 51.68% | Net Buying | Net Selling |
| SCPH | SCPHARMACEUTICALS INC | United States | $168.01M | 36,054,409 | 56.17% | 43.83% | Net Selling | |
| INMB | INMUNE BIO INC | United States | $208.57M | 18,026,473 | 12.71% | 40.66% | Net Buying | Net Buying |
| ORGS | ORGENESIS INC | United States | $18.10M | 34,338,782 | 4.00% | 96.00% | Net Buying | Net Buying |
| PRAX | PRAXIS PRECISION MEDICINES INC | United States | $722.02M | 13,238,349 | 40.09% | 59.91% | Net Buying | Net Selling |
| FTRE | FORTREA HOLDINGS INC | United States | $3.34B | 89,400,000 | 99.87% | 0.13% | Net Buying | Net Selling |
| ELAB | ELEVAI LABS INC | United States | $12.15M | 17,329,615 | 0.15% | 99.85% | ||
| PHAT | PHATHOM PHARMACEUTICALS INC | United States | $587.11M | 58,477,351 | 60.10% | 39.90% | Net Selling | Net Selling |
| LEXX | LEXARIA BIOSCIENCE CORP | Canada | $40.33M | 12,885,673 | 8.82% | 4.82% | ||
| FBIO | FORTRESS BIOTECH INC | United States | $33.66M | 19,234,526 | 24.35% | 62.68% | Net Buying | Net Buying |
| SYBX | SYNLOGIC INC | United States | $21.43M | 11,646,977 | 3.98% | 96.02% | Net Selling | Net Selling |
| MGX | METAGENOMI INC | United States | $236.83M | 37,472,351 | 0.00% | 32.96% | Net Buying | Net Buying |
| CDXC | CHROMADEX CORP | United States | $284.67M | 75,309,118 | 8.22% | 91.78% | Net Buying | |
| OABI | OMNIAB INC | United States | $546.98M | 117,126,046 | 71.51% | 26.39% | Net Buying | Net Buying |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLC | United Kingdom | $294.31M | 1,480,950,456 | 7.28% | 92.72% | Net Selling | |
| AUTL | AUTOLUS THERAPEUTICS PLC | United Kingdom | $1.11B | 265,926,305 | 43.49% | 0.00% | ||
| IBRX | IMMUNITYBIO INC | United States | $6.17B | 673,952,278 | 8.50% | 7.94% | Net Buying | Net Selling |
| HRTX | HERON THERAPEUTICS INC | United States | $392.36M | 150,328,585 | 48.56% | 51.44% | Net Buying | Net Selling |
| PRQR | PROQR THERAPEUTICS NV | Netherlands | $163.52M | 81,354,592 | 22.61% | 0.00% | ||
| RLMD | RELMADA THERAPEUTICS INC | United States | $111.04M | 30,174,202 | 45.13% | 3.43% | Net Buying | |
| MURA | MURAL ONCOLOGY PLC | Ireland | $64.81M | 16,922,550 | 78.93% | 2.66% | ||
| ADTX | ADITXT INC | United States | $3.83M | 1,665,214 | 0.09% | 99.91% | Net Selling | |
| HEPA | HEPION PHARMACEUTICALS INC | United States | $7.99M | 5,472,451 | 7.54% | 92.46% | Net Buying | |
| OLMA | OLEMA PHARMACEUTICALS INC | United States | $596.61M | 55,914,741 | 71.73% | 28.27% | Net Buying | Net Selling |
| IVVD | INVIVYD INC | United States | $288.52M | 119,221,230 | 37.84% | 62.16% | Net Selling | |
| ATXI | AVENUE THERAPEUTICS INC | United States | $2.82M | 590,142 | 4.45% | 95.55% | Net Buying | |
| GOVX | GEOVAX LABS INC | United States | $3.50M | 2,172,272 | 1.21% | 98.79% | Net Buying | Net Buying |
| LXEO | LEXEO THERAPEUTICS INC | United States | $340.56M | 26,668,956 | 60.65% | 25.62% | Net Buying | |
| GLTO | GALECTO INC | United States | $18.98M | 27,112,697 | 14.20% | 24.86% | Net Selling | |
| CARM | CARISMA THERAPEUTICS INC | United States | $67.30M | 41,542,534 | 21.66% | 74.42% | ||
| SGMT | SAGIMET BIOSCIENCES INC | United States | $137.87M | 31,913,887 | 39.98% | 60.02% | Net Buying | Net Buying |
| SLRN | ACELYRIN INC | United States | $427.89M | 98,365,050 | 73.07% | 26.93% | Net Buying | Net Selling |
| MIRA | MIRA PHARMACEUTICALS INC | United States | $10.83M | 14,780,885 | 0.66% | 30.26% | Net Buying | |
| SRZN | SURROZEN INC | United States | $31.99M | 3,198,786 | 5.92% | 94.08% | Net Buying | Net Buying |
| THTX | THERATECHNOLOGIES INC | Canada | $58.85M | 45,980,019 | 33.01% | 0.00% | ||
| IMRX | IMMUNEERING CORP | United States | $48.02M | 29,283,272 | 53.75% | 46.25% | Net Selling | Net Selling |
| RNAC | CARTESIAN THERAPEUTICS INC | United States | $138.20M | 5,398,287 | 54.86% | 45.14% | Net Buying | Net Buying |
| INZY | INOZYME PHARMA INC | United States | $292.80M | 61,771,977 | 54.64% | 45.36% | Net Buying | Net Selling |
| ALXO | ALX ONCOLOGY HOLDINGS INC | United States | $770.34M | 50,152,082 | 75.63% | 24.37% | Net Selling | Net Selling |
| EWTX | EDGEWISE THERAPEUTICS INC | United States | $1.82B | 93,110,623 | 84.20% | 15.80% | Net Buying | Net Selling |
| XERS | XERIS BIOPHARMA HOLDINGS INC | United States | $265.46M | 140,453,467 | 42.66% | 15.51% | Net Buying | Net Buying |
| IRON | DISC MEDICINE INC | United States | $735.25M | 24,681,028 | 44.57% | 55.43% | Net Selling | Net Selling |
| IMVT | IMMUNOVANT INC | United States | $4.19B | 145,292,970 | 44.83% | 55.17% | Net Buying | Net Selling |
| FBRX | FORTE BIOSCIENCES INC | United States | $25.99M | 36,394,882 | 51.83% | 22.30% | Net Buying | Net Selling |
| ONCT | ONCTERNAL THERAPEUTICS INC | United States | $25.88M | 2,959,645 | 13.07% | 86.93% | Net Selling | Net Buying |
| TSBX | TURNSTONE BIOLOGICS CORP | United States | $62.83M | 23,099,335 | 46.24% | 53.76% | Net Buying | |
| DRTS | ALPHA TAU MEDICAL LTD | Israel | $173.48M | 69,670,612 | 2.64% | 0.00% | ||
| APVO | APTEVO THERAPEUTICS INC | United States | $527.60k | 533,464 | 34.00% | 66.00% | ||
| RCKT | ROCKET PHARMACEUTICALS INC | United States | $2.12B | 90,504,248 | 54.89% | 45.11% | Net Selling | Net Selling |
| VIGL | VIGIL NEUROSCIENCE INC | United States | $111.76M | 36,884,712 | 44.03% | 55.97% | Net Buying | |
| NNVC | NANOVIRICIDES INC | United States | $13.31M | 11,779,000 | 2.27% | 97.73% | ||
| RAPT | RAPT THERAPEUTICS INC | United States | $289.86M | 34,797,702 | 66.33% | 33.67% | Net Selling | |
| VRPX | VIRPAX PHARMACEUTICALS INC | United States | $2.62M | 1,171,233 | 4.26% | 95.74% | ||
| REPL | REPLIMUNE GROUP INC | United States | $426.65M | 61,387,786 | 67.71% | 32.29% | Net Selling | |
| TRML | TOURMALINE BIO INC | United States | $406.24M | 25,646,509 | 43.00% | 57.00% | Net Selling | |
| LBPH | LONGBOARD PHARMACEUTICALS INC | United States | $831.06M | 38,880,054 | 42.51% | 0.08% | Net Selling | |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | United States | $2.89B | 63,886,757 | 72.47% | 27.53% | Net Buying | Net Selling |
| COGT | COGENT BIOSCIENCES INC | United States | $782.47M | 103,913,396 | 87.38% | 11.29% | Net Buying | Net Buying |
| RZLT | REZOLUTE INC | United States | $131.16M | 39,625,271 | 21.83% | 78.17% | Net Buying | Net Buying |
| CRVS | CORVUS PHARMACEUTICALS INC | United States | $94.15M | 49,038,582 | 39.12% | 60.38% | Net Buying | |
| ZURA | ZURA BIO LTD | United States | $201.40M | 43,593,678 | 27.09% | 72.91% | Net Selling | Net Buying |
| ATHE | ALTERITY THERAPEUTICS LTD | Australia | $11.49M | 2,802,360,380 | 0.00% | 0.00% | ||
| SRRK | SCHOLAR ROCK HOLDING CORP | United States | $1.20B | 77,866,281 | 60.56% | 39.44% | Net Buying | Net Selling |
| CRGX | CARGO THERAPEUTICS INC | United States | $800.25M | 39,363,052 | 71.34% | 28.66% | Net Buying | |
| SNTI | SENTI BIOSCIENCES INC | United States | $16.93M | 45,755,021 | 25.05% | 52.51% | ||
| ADCT | ADC THERAPEUTICS SA | Switzerland | $404.39M | 82,529,549 | 41.10% | 37.51% | ||
| ELDN | ELEDON PHARMACEUTICALS INC | United States | $59.80M | 24,813,130 | 23.14% | 76.86% | ||
| ACHL | ACHILLES THERAPEUTICS PLC | United Kingdom | $33.03M | 41,082,948 | 53.02% | 0.00% | ||
| GOSS | GOSSAMER BIO INC | United States | $166.93M | 225,582,250 | 86.47% | 13.53% | Net Buying | Net Selling |
| INTS | INTENSITY THERAPEUTICS INC | United States | $52.92M | 13,709,377 | 0.00% | 14.63% | ||
| ALVR | ALLOVIR INC | United States | $91.67M | 114,869,175 | 14.62% | 85.38% | Net Buying | Net Selling |
| NMRA | NEUMORA THERAPEUTICS INC | United States | $1.47B | 158,886,101 | 21.44% | 78.56% | Net Buying | |
| COYA | COYA THERAPEUTICS INC | United States | $126.23M | 14,542,579 | 19.41% | 14.62% | Net Buying | |
| TCBP | TC BIOPHARM (HOLDINGS) PLC | United Kingdom | $4.66M | 63,902,641 | 0.12% | 11.35% | ||
| TCON | TRACON PHARMACEUTICALS INC | United States | $4.23M | 2,275,225 | 6.34% | 93.66% | Net Selling | |
| ENTA | ENANTA PHARMACEUTICALS INC | United States | $320.94M | 21,155,983 | 58.46% | 41.54% | Net Selling | Net Selling |
| ACRV | ACRIVON THERAPEUTICS INC | United States | $217.09M | 22,636,951 | 46.35% | 53.65% | Net Buying | Net Buying |
| TENX | TENAX THERAPEUTICS INC | United States | $7.52M | 1,958,245 | 7.69% | 92.31% |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.